Literature DB >> 12057133

Occult breast cancer and axillary mass.

K L Brill1, D R Brenin.   

Abstract

Occult breast cancer presenting with axillary metastases is an unusual presentation and can be a diagnostic and therapeutic challenge. A comprehensive work-up, including mammogram, sonogram, magnetic resonance imaging, and even pathologic examination of the mastectomy specimen may not disclose the primary tumor in up to one third of patients. Traditionally, occult breast cancer is treated with total mastectomy and axillary dissection, but accumulating data suggest that primary breast irradiation following axillary dissection may provide an equivalent survival with the advantage of breast conservation. Occult breast cancer patients are eligible for adjuvant chemotherapy and radiation as stage II/ III node-positive patients would be treated. Overall, the prognosis for occult breast cancer is equivalent to or slightly better than staged counterparts with detectable primary breast tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12057133     DOI: 10.1007/s11864-001-0057-x

Source DB:  PubMed          Journal:  Curr Treat Options Oncol        ISSN: 1534-6277


  22 in total

1.  An Address ENTITLED SOME CLINICAL FACTS REGARDING MAMMARY CANCER.

Authors:  H C Cameron
Journal:  Br Med J       Date:  1909-03-06

2.  Postmastectomy radiation: a modest benefit prevails for high risk patients.

Authors:  B Fowble
Journal:  Cancer       Date:  1997-03-15       Impact factor: 6.860

3.  Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxy-D-glucose.

Authors:  N Avril; J Dose; F Jänicke; S Ziegler; W Römer; W Weber; M Herz; W Nathrath; H Graeff; M Schwaiger
Journal:  J Natl Cancer Inst       Date:  1996-09-04       Impact factor: 13.506

4.  Treatment of patients with isolated axillary nodal metastases from an occult primary carcinoma consistent with breast origin.

Authors:  N Ellerbroek; F Holmes; E Singletary; H Evans; M Oswald; M McNeese
Journal:  Cancer       Date:  1990-10-01       Impact factor: 6.860

5.  Breast carcinoma presenting as axillary metastases without evidence of a primary tumor.

Authors:  M Merson; S Andreola; V Galimberti; R Bufalino; S Marchini; U Veronesi
Journal:  Cancer       Date:  1992-07-15       Impact factor: 6.860

6.  Occult breast carcinoma presenting with axillary lymph node metastases: a follow-up study of 48 patients.

Authors:  P P Rosen; M Kimmel
Journal:  Hum Pathol       Date:  1990-05       Impact factor: 3.466

7.  Axillary lymph node metastasis from an occult breast cancer.

Authors:  J Patel; T Nemoto; D Rosner; T L Dao; J W Pickren
Journal:  Cancer       Date:  1981-06-15       Impact factor: 6.860

8.  Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study.

Authors:  B Fisher; J P Costantino; D L Wickerham; C K Redmond; M Kavanah; W M Cronin; V Vogel; A Robidoux; N Dimitrov; J Atkins; M Daly; S Wieand; E Tan-Chiu; L Ford; N Wolmark
Journal:  J Natl Cancer Inst       Date:  1998-09-16       Impact factor: 13.506

9.  Occult breast cancer presenting with axillary metastases. Updated management.

Authors:  P L Baron; M P Moore; D W Kinne; F C Candela; M P Osborne; J A Petrek
Journal:  Arch Surg       Date:  1990-02

10.  Occult primary adenocarcinoma with axillary metastases.

Authors:  M M Kemeny; D E Rivera; J J Terz; J R Benfield
Journal:  Am J Surg       Date:  1986-07       Impact factor: 2.565

View more
  4 in total

Review 1.  Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis.

Authors:  Oluwadamilola M Fayanju; Carolyn R T Stoll; Susan Fowler; Graham A Colditz; Donna B Jeffe; Julie A Margenthaler
Journal:  Ann Surg Oncol       Date:  2013-08-22       Impact factor: 5.344

2.  Male occult triple-negative breast cancer.

Authors:  Basma Alsayed; Hussain Adnan Abdulla; Hadi Alaskar; Ali Dhaif
Journal:  BMJ Case Rep       Date:  2019-04-20

3.  Male occult triple-negative breast cancer with dermatomyositis: a case report and review of the literature.

Authors:  Le Zhang; Chenghua Zhang; Zhaoying Yang; Miao He; Lijuan Zhang; Shereen Ezzat; Xi Liang
Journal:  Onco Targets Ther       Date:  2017-11-14       Impact factor: 4.147

4.  Breast cancer presenting as unilateral arm edema.

Authors:  Shaheen Zakaria; Ruth Johnson; Barbara A Pockaj; Amy C Degnim
Journal:  J Gen Intern Med       Date:  2007-05       Impact factor: 5.128

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.